Literature DB >> 26725086

Defining the phenotype of restless legs syndrome/Willis-Ekbom disease (RLS/WED): a clinical and polysomnographic study.

Fabrizio Rinaldi1,2, Andrea Galbiati2,3, Sara Marelli2,3, Maria Cusmai3, Alessandro Gasperi3, Alessandro Oldani2, Marco Zucconi2, Alessandro Padovani1, Luigi Ferini Strambi4,5.   

Abstract

Clinical features variability between familial and sporadic restless legs syndrome/Willis-Ekbom disease (RLS/WED) has been previously reported. With this retrospective cohort study, we aimed to determine the clinical and polysomnographic characteristics of 400 RLS/WED patients. Patients with familial RLS/WED were significantly younger than sporadic RLS/WED, while clinical and polysomnographic characteristics were similar in both groups. No difference was found for the age-at-onset between idiopathic and secondary RLS/WED. Periodic limb movements (PLM) index and REM sleep time were higher in idiopathic RLS/WED. Time of onset of symptoms was in the evening or at bedtime in 28.04 and 37.80% of patients, respectively, while in 21.34% of patients onset was more than 1 h after sleep onset. Impulse control and compulsive behaviours (ICBs) were found in 13.29% patients on dopamine agonist therapy. Our analyses support the hypothesis that patients with a familial history of RLS/WED may have a genetic component. Nevertheless, the dichotomy between early and late onset disease seems to be less sharp than previously reported. A large proportion of RLS/WED patients can have atypical features, therefore making the diagnosis challenging. Some cases can be missed even when the patient refers to a sleep specialist, as revealed by the partial absence of daytime symptoms, the high comorbidity with insomnia and other sleep complaints and the high percentage of symptoms beginning after sleep onset. This draws attention on the importance of a careful evaluation of the patient, to recognize potentially treatable secondary forms of RLS/WED.

Entities:  

Keywords:  Age of onset; Familial RLS/WED; Idiopathic RLS/WED; Impulse control and compulsive behaviours; Polysomnography; Restless legs syndrome/Willis-Ekbom disease

Mesh:

Year:  2016        PMID: 26725086     DOI: 10.1007/s00415-015-7994-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  41 in total

1.  The official World Association of Sleep Medicine (WASM) standards for recording and scoring periodic leg movements in sleep (PLMS) and wakefulness (PLMW) developed in collaboration with a task force from the International Restless Legs Syndrome Study Group (IRLSSG).

Authors:  Marco Zucconi; Raffaele Ferri; Richard Allen; Paul Christian Baier; Oliviero Bruni; Sudhansu Chokroverty; Luigi Ferini-Strambi; Stephany Fulda; Diego Garcia-Borreguero; Wayne A Hening; Max Hirshkowitz; Birgit Högl; Magdolna Hornyak; Martin King; Pasquale Montagna; Liborio Parrino; Giuseppe Plazzi; Mario G Terzano
Journal:  Sleep Med       Date:  2006-02-03       Impact factor: 3.492

2.  Age-at-onset in restless legs syndrome: a clinical and polysomnographic study.

Authors:  S Whittom; Y Dauvilliers; M-H Pennestri; F Vercauteren; N Molinari; D Petit; J Montplaisir
Journal:  Sleep Med       Date:  2007-07-17       Impact factor: 3.492

3.  Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria--history, rationale, description, and significance.

Authors:  Richard P Allen; Daniel L Picchietti; Diego Garcia-Borreguero; William G Ondo; Arthur S Walters; John W Winkelman; Marco Zucconi; Raffaele Ferri; Claudia Trenkwalder; Hochang B Lee
Journal:  Sleep Med       Date:  2014-05-17       Impact factor: 3.492

4.  Epidemiology of restless legs symptoms in adults.

Authors:  B Phillips; T Young; L Finn; K Asher; W A Hening; C Purvis
Journal:  Arch Intern Med       Date:  2000-07-24

5.  Restless legs syndrome in end-stage renal disease.

Authors:  J W Winkelman; G M Chertow; J M Lazarus
Journal:  Am J Kidney Dis       Date:  1996-09       Impact factor: 8.860

6.  Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.

Authors:  M Saletu; P Anderer; G Saletu-Zyhlarz; C Hauer; B Saletu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2002-08       Impact factor: 5.270

7.  Increased electroencephalographic high frequencies during the sleep onset period in patients with restless legs syndrome.

Authors:  Raffaele Ferri; Filomena I I Cosentino; Mauro Manconi; Francesco Rundo; Oliviero Bruni; Marco Zucconi
Journal:  Sleep       Date:  2014-08-01       Impact factor: 5.849

8.  Predictors of impulsivity and reward seeking behavior with dopamine agonists.

Authors:  William G Ondo; Dejian Lai
Journal:  Parkinsonism Relat Disord       Date:  2007-08-16       Impact factor: 4.891

Review 9.  The hyperarousal model of insomnia: a review of the concept and its evidence.

Authors:  Dieter Riemann; Kai Spiegelhalder; Bernd Feige; Ulrich Voderholzer; Mathias Berger; Michael Perlis; Christoph Nissen
Journal:  Sleep Med Rev       Date:  2009-05-28       Impact factor: 11.609

10.  Iron and the restless legs syndrome.

Authors:  E R Sun; C A Chen; G Ho; C J Earley; R P Allen
Journal:  Sleep       Date:  1998-06-15       Impact factor: 5.849

View more
  5 in total

1.  Cryptic Restlessness and Sleepwalking.

Authors:  Michael Howell
Journal:  Sleep       Date:  2016-07-01       Impact factor: 5.849

2.  Treatment Options in Intractable Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED).

Authors:  Fabrizio Rinaldi; Andrea Galbiati; Sara Marelli; Luigi Ferini Strambi; Marco Zucconi
Journal:  Curr Treat Options Neurol       Date:  2016-02       Impact factor: 3.598

3.  Treatment initiation and utilization patterns of pharmacotherapies for early-onset idiopathic restless legs syndrome.

Authors:  Brianna Costales; Scott M Vouri; Joshua D Brown; Barry Setlow; Amie J Goodin
Journal:  Sleep Med       Date:  2022-05-13       Impact factor: 4.842

Review 4.  Restless Legs Syndrome across the Lifespan: Symptoms, Pathophysiology, Management and Daily Life Impact of the Different Patterns of Disease Presentation.

Authors:  Giuseppe Didato; Roberta Di Giacomo; Giuseppa Jolanda Rosa; Ambra Dominese; Marco de Curtis; Paola Lanteri
Journal:  Int J Environ Res Public Health       Date:  2020-05-22       Impact factor: 3.390

5.  Prevalence and Clinical Characteristics of the Restless Legs Syndrome (RLS) in Patients Diagnosed with Attention-Deficit Hyperactivity Disorder (ADHD) in Antioquia.

Authors:  Ana Carolina Sierra Montoya; Sandra Catalina Mesa Restrepo; Jorge Mauricio Cuartas Arias; William Cornejo Ochoa
Journal:  Int J Psychol Res (Medellin)       Date:  2018 Jan-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.